On July 16, 2025, B of A Securities made significant changes to its evaluation of Ardent Health (ARDT, Financial). Analyst Kevin Fischbeck announced a downgrade in the stock's rating from 'Neutral' to 'Underperform'.
In addition to the rating change, the price target for Ardent Health (ARDT, Financial) has been lowered. The new price target is set at $14.60 USD, down from the previous target of $15.50 USD. This adjustment reflects a percentage change of -5.81%.
The downgrade by B of A Securities follows their analyst's assessment of Ardent Health's (ARDT, Financial) current market position and future outlook, indicating a less favorable view of the stock's performance potential.